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1. Introduction 
Down syndrome (DS), the most common chromosomal abnormality with a prevalence of 1 
case per 600 live births (Dennis & Marder,2001), has many manifestations that can affect 
multiple organ systems (American Academy of Pediatrics Comittee on Genetics, 2001; 
Kallen et al., 1996) including urological abnormalities which have been recognized 
throughout urinary tract (Ariel et al., 1991; Berg et al.,1960; Ahmed, 1990; Kravtzova et al., 
1975; Handel et al., 2003; Kupferman et al., 1996; Bielek et al., 1996; Narashiman & Gupta, 
2004; Koksal et al., 2003; Lang et al., 1987; Paulozzi et al., 1997). The extra copy of 
chromosome 21 has been suggested as an actor underlying the accompanied phenotypic 
abnormalities in the syndrome (Lejeune, 1959). 
Berg et al. described the first cases of urological anomalies associated with DS in their study 
of 141 DS autopsy cases and found 1 patient (0.7%) with renal agenesis and 5 patients (3.6%) 
with horseshoe kidney (Berg et al., 1960). Glomerular microcysts, renal hypoplasia and 
obstructive uropathy have also been recognized as the most common upper urinary tract 
anomalies in DS and their incidences were reported by Ariel et al. who examined 124 
autopsy cases of DS for abnormalities in urinary tract system to be as high as 23.7% (23 of 97 
patients), 21.4% (18 of 84 patients), and 6.45% (8 of the 124 cases), respectively (Ariel et al., 
1991). In addition, simple renal cysts were also found in 7 of 124 cases (5.6%). 
Anomalies in ureteral structure has also been identified in DS (Ariel et al., 1991; Kravtzova 
et al., 1975; Handel et al., 2003). The incidence of obstructed megaureter or 
hydroureteronephrosis was reported in 2 of 124 cases (1.6%), while ureteral atresia was seen 
in 1 of 124 cases (0.8%) (Ariel et al., 1991). In addition, vesicoureteral reflux (Kravtzova et al., 
1975), ureterovesical junction and ureteropelvic junction obstructions have also been 
described in patients with trisomy 21 (Handel et al., 2003). 
Trisomy 21 is one of genetic disorders that can also be accompanied by some urological 
abnormalities in lower urinary tract. Non-neurogenic neurogenic bladder (NNB) has been 
reported as a functional lower urinary tract abnormality seen in DS.  Handel et al. 
retrospectively reviewed 26 patients with trisomy 21 and found 4 patients (15.4%) with NNB 
(Handel et al., 2003).  Posterior urethral valve has also been identified in patients with 
trisomy 21 (Bielek et al., 1996; Narashiman & Gupta, 2004; Koksal et al., 2003; Lang DJ et al., 
1987). Bielek et al who reviewed 48 cases of posterior urethral valves found 4 patients with 
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DS (Bielek et al., 1996). Hypospadia has also a higher incidence in patients with the 
syndrome (Paulozzi et al., 1997). 
There is a lack of awareness regarding DS related urological manifestations in daily clinical 
practice. The associated urological anomalies have received little attention from physicians 
especially for NNB which often cause the delay in referring the patients for further 
management. In this chapter we will focus on the NNB which represents voiding 
dysfunction due to functional bladder outlet obstruction recognized in DS. The discussion 
will include the evaluation and management of this particular disorder. Urodynamic 
assessment as the most important part in the diagnosis of NNB will also be described. 
2. Dysfunctional voiding of non-neurogenic neurogenic bladder in Down 
Syndrome 
2.1 Historical note 
Non-neurogenic neurogenic bladder, the most severe form of dysfunctional voiding, is a 
pure functional bladder outlet obstruction without any neurological abnormalities which 
was described by Hinman (Hinman, 1986). However, it was first described by Beer who 
reported four patients with chronic urinary retention and upper urinary tract changes 
without any evidence of neurological pathology (Beer, 1915). He observed the disharmony 
between the detrusor and sphincter muscles in the patients.  
Incoordination syndrome of voiding contraction reflex was also found by Laidley (Ladley, 
1942). The syndrome was then called “achalasia of the urinary tract”. Paquin et al. reported 
symptoms of dysfunctional voiding with large bladder in 27 children and the term 
“megacystis syndrome” was used to represent the syndrome (Paquin et al., 1960). Ambrose 
and Swanson reported the 13 children with hypertonic detrusor contraction without any 
neurologic lesion and labeled the syndrome as “hypertonic-type neurogenic bladder” 
(Ambrose & Swanson, 1960). 
Hinman & Baumann  reported voiding difficulties in children associated with upper urinary 
tract deterioration without any anatomical obstruction or neurologic lesion with the 
identified psychological disorder (Hinman & Baumann, 1972). The term “non-neurogenic 
neurogenic bladder” was introduced in order to emphasize the absence of neurologic 
lesions. The cases were followed for 15 years and then reported with new term “Hinman 
syndrome” according to the important of psychological factors which contribute to the 
syndrome and change the previous term which was not appropriate and cause confusion. 
However, the underlying psychological disturbances were not recognized in the syndrome 
as reported by Allan (Allan ,1977).  
Non neurogenic-neurogenic syndrome in association with trisomy 21 was first identified by 
Handel et al. who reviewed 26 children with DS (all boys) and found higher incidence of 
NNB compare to other urological abnormalities in DS (Handel et al., 2003). Hicks et al 
reported the first women with NNB associated with DS and also found higher incidence of 
NNB cases in trisomy 21 (Hicks et al., 2007).  
2.2 Epidemiology 
The true prevalence of NNB has not been reported. The available prevalence is only based 
on data obtained from some centers. Groutz et al. reported that NNB was found in 2% of 
patients who underwent video-urodynamic studies but the real prevalence would be even 
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higher (Groutz et al., 2001). Jorgensen et al. reported lower prevalence of NNB (0.5%) among 
patients referred for urodynamic evaluation (Jorgensen et al., 1982).  
Handel et al. reported a higher incidence of NNB in patients with trisomy 21. Among 26 
patients with DS who were reviewed, 4 (15.4%) was reported to have NNB (Handel et al., 
2003). Hicks et al also found higher incidence of NNB cases in DS (Hicks et al., 2007).23 Non-
neurogenic neurogenic bladder has been reported not only in infant and children but also in 
adult patients (Handel et al., 2003; Hicks et al., 2007; Jayanthi et al., 1997; Kai et al., 2007). 
2.3 Etiology 
The etiology of the disease is not clearly defined. Some evidences suggest overtraining of the 
pelvic floor to avoid urine loss due to not only various emotional conditions such as 
depression, phobias, stress, trauma associated with toilet training but also psychiatric 
diseases, the presence of detrusor overactivity and other associated voiding dysfunctions as 
an underlying factors which may contribute to cause NNB (Hoebeke et al., 1996; Koff et al., 
1979; Goldston & Perlmutter, 1973; Schimtt, 1982; Ellsworth, 1995). The well known mental 
retardation and psychological problems in patients with DS may also explain the higher 
incidence of NNB in this trisomy 21.  
In normal voiding function, bladder filling is accommodated at low bladder pressures with 
a bladder outlet that remains closed while bladder emptying requires a coordinated and 
sustained contraction of the bladder muscle with concomitant relaxation of the external 
urethral sphincter. The reflex of micturition is controlled by parasympathetic and somatic 
components of the sacral spinal cord and sympathetic innervation. 
In NNB, functional bladder outlet obstruction is caused by active contractions of the 
voluntary external sphincters during voiding. The inability to inhibit the detrusor 
contraction reflex as well as overactivity of the external sphincter as compensation has 
become fundamental characteristics of patients with NNB (Hinman, 1986). The 
dyssynergistic voiding pattern created by the incoordination between the bladder and 
sphincter contraction reflex may result in impairment of renal function caused by functional 
obstruction (obstructive uropathy) due to unacceptable high voiding pressure with potential 
upper and lower urinary tract deterioration . 
2.4 Diagnosis 
General history-taking should include relevant questions for the screening of NNB. A 
thorough patient history will indicate incontinence associated with chronic urinary 
retention. History-taking in patients with DS is difficult especially in children due to the 
impairment of cognitive function and should be supplemented by information obtained 
from the parents. Because of the intelligence level, some of the existence as well as other 
underlying factors in patients with DS may be masked or neglected resulting in the delay of 
the diagnosis which often seen in clinical practice (Handel et al., 2003; Kai et al., 2007; 
Fernandez & Moore., 1986). 
Although unerderlying factors could not be found in some cases, It is important to make 
sure that history taking have already included all the underlying factors of NNB which may 
guide to the diagnosis (Goldston & Perlmutter, 1973; Schmitt, 1982; Ellsworth et al., 1995). 
Neurological symptoms and abnormalities will not be present in NNB but should be 
confirmed by carefully clinical examination. Laboratory results may show elevated serum 
creatinine and reduce clearance or decreased renal function with or without signs of urinary 
tract infection in most of the cases. 
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Ultrasound is useful to evaluate bladder after voiding which can show residual urine 
volume as well as determine the bladder thickness. In addition, ultrasound is also important 
to detect the upper urinary tract dilatation with or without dilatation of the ureters as a 
complication of functional obstruction in NNB. In trisomy 21, this tool is also useful to 
identify other associated organ anomalies including abnormalities in the kidney.  
To diagnose NNB in trisomy 21 patients, other associated anomalies such as Hirschsprung’s 
disease, spinal cord defects, and posterior urethral valves must be excluded first before 
concluding that they have a functional rather than anatomical obstruction especially those 
who present with constipation, recurrent urinary tract infections, incontinence and voiding 
dysfunction (Handel et al., 2003). In order to rule out the neurological lesions, imaging 
studies of computed tomography (CT) scans and magnetic resonance imaging (MRI) should 
be performed (Johnson et al., 1992). 
Non-neurogenic neurogenic bladder should be suspected if negative results have been 
confirmed by standard rectal biopsies and urological evaluation demonstrates the absence 
of anatomical obstruction and neurological evaluation including imaging studies confirms 
the absence of any neurologic lesions (Handel et al., 2003).  
2.4.1 Voiding-cystourethrography 
Voiding-cystourethrography is an important radiologic tool to show varying grade of 
vesico-ureter reflux in some cases of NNB.  In addition, it also shows bladder appearance as 
a result of functional obstruction such as a trabeculated and enlarged bladder with a lot of 
residual urine still remains in the bladder after voiding without any evidence of mechanical 
obstruction (Fig. 1). 
 
 
Fig. 1. Voiding cystourethrography shows a deformity of the bladder wall with 
trabeculation (left) and narrowing of the posterior urethra as pointed by white arrows with 
significant residual urine (right) without vesico-urethral reflux 
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In contrast, anatomical obstruction by posterior urethral valve can be identified by posterior 
urethral dilatation with poor visualization of the anterior urethra. However, it is important 
to note that the appearance of posterior urethra may entirely normal during early voiding 
but distended after contraction of the external sphincter as voiding progress which was 
found in 4 patients who previously diagnosed with NNB as reported by Johnson et al who 
reviewed the genitourinary images of six boys in whom NNB was diagnosed in the past 5 
years (Johnson et al., 1992). 
2.4.2 Uroflowmetry 
Uroflowmetry is useful for the screening of NNB since it is able to measure the urinary 
stream during the voiding phase, providing information of bladder and outlet function 
(Allan & Bright, 1978; Stanton et al., 1983). In uroflowmetry measurement, it is important to 
pay attention on the the flow pattern beside other important parameters (Vijverberg et al., 
1997). Normal urine flow is continuous bell-shaped curve. Continuous plateau shape curve 
(lower urinary flow rate with prolonged voiding time) is typical for anatomical obstruction.  
In contrast, functional obstruction is typically reflected by a staccato pattern  as interrupted 
flow of urine occurs due to uninhibited external sphincter contraction and usually 
demonstrates intermittency with reduced flow rates and prolonged voiding time (Fig. 2). 
The results also depend on the stage of the disease since the above pattern is hardly ever 
seen in advance cases with atonia of the bladder and poor detrusor contractility due to 
decompensated bladder. Uroflowmetry can also be used as a tool for follow-up of bladder 
training, and biofeedback training (Vijverberg et al., 1997; Hellstrom et al., 1987; Hjalmas, 
1988; Griffiths & Scholtmeijer, 1984; Wear et al., 1979). 
 
 
 
 
 
Fig. 2. The illustration of normal and abnormal uroflowmetry patterns. 
2.4.3 Urodynamics 
Urodynamics study is the gold standard for the diagnosis of patients with voiding 
dysfunction. (Nitti, 2005) Hypertonicity, instability with impaired external sphincter 
relaxation during micturation are typical characteristics in patients with NNB (Allan & 
Bright, 1978). Electromyography (EMG) shows a spastic activity with a high amplitude 
during voiding phase (Fig. 3).  
Normal Plateau Staccato 
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True detrusor-external sphincter dyssynergia and NNB can be differentiated 
urodynamically (Rudy & Woodside, 1991). Detrusor-external sphincter dyssynergia is 
characterized urodynamically by increasing EMG activity during upslope and decreasing 
activity during down slope of the intravesical pressure tracing during a detrusor 
contraction. However, NNB is characterized urodynamically by quieting of the EMG during 
upslope and augmented activity during the down slope of the detrusor contraction. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Urodynamic results indcate a decrease in the bladder sensation without detrusor 
overactivity. A low urinary flow rate with a high detrusor pressure is shown in the voiding 
phase. Electromyography shows a spastic activity with a high amplitude during voiding. 
(Filling rate = 50 ml/min). 
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2.5 Management 
Management of patients with NNB must be focused on the relaxation of external urethral 
sphincter muscle in order to obtain a more physiological micturation with relaxed sphincter 
muscle during voiding and to restore the balance of voiding and voluntary sphincter 
contraction reflex to prevent upper and lower urinary tract deterioration. The additional 
goals of treatment include prevention of urinary tract infections with proper antibiotics. The 
management should be addressed to all patients regardless of their intellectual capacity 
including those with trisomy 21. The intellectual Impairment of patients with DS may cause 
some difficulties in conducting the treatment.  
Anti-cholinergics and alpha blocker therapy either alone or in combination may be useful in 
the treatment of NNB (Krane & Olsson, 1973; Paul et al., 1999; Bogaert et al., 2004) since 
significant improvement in emptying was shown in neurogenic cases treated with non 
selective alpha blocker (Krane & Olsson, 1973). If there is no response to conservative 
treatment, intermittent catheterization may be required. Trisomy 21 associated NNB 
patients with abnormal voiding mechanism against a closed sphincter may deal with the 
difficulty in conducting urethral clean intermittent catheterization due to their intellectual 
limitation (Handel et al, 2003).   
Surgical treatment for renal preservation is also required for social continence. Self-
catheterization protocols via the catheterizable stoma may allow trisomy 21 patients with a 
sufficient intellectual level master such techniques. Patients with NNB who are refractory to 
conservative treatment or present with an advanced pathological condition may require 
surgical intervention. Augmentation of the bladder in order to increase the bladder capacity 
may still be required in those in whom the upper tracts are threatened (Handel et al, 2003). 
The use of Botulinum-A toxin injection into detrusor or the external sphincter may help 
cause striated muscle paralysis and may also restore voiding function especially in those 
who failed with drug therapy (Schurch et al., 1996). Patients with NNB in DS could also be 
performed such procedure. This particular treatment is dose dependent and also reversible. 
Injection may be necessary in every two months.  
3. Summary  
Children with trisomy 21 have many associated multi organ anomalies including urological 
abnormalities. Non-neurogenic neurogenic bladder is the most frequent DS associated lower 
urinary tract disorder. Early diagnosis and prompt management should be conducted in 
order to prevent upper urinary tract deterioration. According to the high incidence of NND 
in DS, early and regular sonographic and urodynamic evaluation of the bladder function is 
mandatory in patients with Down syndrome. 
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